JUVENILE MYELOMONOCYTIC LEUKEMIA
Clinical trials for JUVENILE MYELOMONOCYTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new JUVENILE MYELOMONOCYTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for JUVENILE MYELOMONOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with tough leukemia: targeted drug shows promise
Disease control OngoingThis study tests a drug called trametinib in children with a rare blood cancer (juvenile myelomonocytic leukemia) that has returned or not responded to treatment. The drug works by blocking certain enzymes that help cancer cells grow. The goal is to see if it can shrink or contro…
Matched conditions: JUVENILE MYELOMONOCYTIC LEUKEMIA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Scientists hunt for blood cancer clues in patient samples
Knowledge-focused ENROLLING_BY_INVITATIONThis study collects blood and bone marrow samples from up to 550 people with blood cancers like leukemia, lymphoma, and myelodysplastic syndrome. Researchers will study the cells, genes, and proteins in these samples to better understand how these cancers develop and to find new …
Matched conditions: JUVENILE MYELOMONOCYTIC LEUKEMIA
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
New testing method may guide targeted treatments for young leukemia patients
Knowledge-focused OngoingThis study looks at whether a special type of testing, called leukemia profiling, can help find personalized treatment options for children and young adults up to age 30 with recurrent, refractory, or high-risk leukemias. Researchers analyze the genetic changes in each patient's …
Matched conditions: JUVENILE MYELOMONOCYTIC LEUKEMIA
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC